酶的部分可逆抑制及其代谢和药物毒理学影响
Patrick Masson1, Aliya R Mukhametgalieva1
1Biochemical Neuropharmacology Laboratory, Kazan Federal University, 18 ul. Kremlevskaya, 420008 Kazan, Russia.
International journal of molecular sciences
|August 26, 2023
概括
部分酶抑制或过度抑制发生在抑制剂形成生产性复合物时,导致剩余的酶活性. 这种不常见的机制不同于完全抑制,影响代谢过程,药理学和毒理学.
科学领域:
- 生物化学 生物化学
- 酶学 是一种酶学.
背景情况:
- 部分可逆抑制是一种不常见的酶抑制机制.
- 它是由一个富有成效的酶抑制剂复合体引起的,与完全抑制不同.
研究的目的:
- 审查部分酶抑制的理论和分析方法.
- 讨论这种抑制在代谢过程,药理学和毒理学中的重要性.
主要方法:
- 酶动力学的分析.
- 对剂量反应曲线的解释.
- 综述现有关于超标抑制的文献.
主要成果:
- 部分抑制剂在酶动力学中产生超标图,与完全抑制剂的线性图形成鲜明对比.
- 部分抑制剂的剂量反应曲线显示,在高度的抑制剂下,残留的酶活性.
结论:
- 部分可逆抑制是一种独特的机制,具有独特的动力特性.
- 了解这种抑制对于代谢研究,药物开发和理解毒理学影响至关重要.
相关概念视频
Enzyme Inhibition
78.7K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.7K
Feedback Inhibition
54.0K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
54.0K
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
279
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
279
Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.9K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.9K
Phase I Reactions: Reductive Reactions
227
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
227
Drug Biotransformation: Overview
2.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.5K


